1. Home
  2. STTK vs TWIN Comparison

STTK vs TWIN Comparison

Compare STTK & TWIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shattuck Labs Inc.

STTK

Shattuck Labs Inc.

HOLD

Current Price

$3.35

Market Cap

119.0M

Sector

Health Care

ML Signal

HOLD

Logo Twin Disc Incorporated

TWIN

Twin Disc Incorporated

HOLD

Current Price

$17.02

Market Cap

224.5M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
STTK
TWIN
Founded
2016
1918
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
119.0M
224.5M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
STTK
TWIN
Price
$3.35
$17.02
Analyst Decision
Buy
Strong Buy
Analyst Count
5
1
Target Price
$4.00
$12.00
AVG Volume (30 Days)
424.7K
27.7K
Earning Date
11-06-2025
02-04-2026
Dividend Yield
N/A
0.93%
EPS Growth
N/A
N/A
EPS
N/A
0.02
Revenue
$1,000,000.00
$347,837,000.00
Revenue This Year
N/A
$10.79
Revenue Next Year
N/A
$8.43
P/E Ratio
N/A
$924.96
Revenue Growth
N/A
14.24
52 Week Low
$0.69
$6.16
52 Week High
$3.38
$17.30

Technical Indicators

Market Signals
Indicator
STTK
TWIN
Relative Strength Index (RSI) 72.56 60.25
Support Level $2.82 $15.06
Resistance Level $3.29 $18.00
Average True Range (ATR) 0.23 0.62
MACD 0.00 0.18
Stochastic Oscillator 93.75 67.18

Price Performance

Historical Comparison
STTK
TWIN

About STTK Shattuck Labs Inc.

Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.

About TWIN Twin Disc Incorporated

Twin Disc Inc is a United States-based firm engaged in the manufacture and sale of marine and heavy-duty off-highway power transmission equipment. The company operates its business through two reportable segments: Manufacturing and Distribution. Its product portfolio includes marine transmissions, surface drives, propellers, and boat management systems as well as power-shift transmissions, hydraulic torque converters, power take-offs, industrial clutches, and control systems.

Share on Social Networks: